This article was originally published in The Tan Sheet
Online testing firm announces 20 of 21 alpha-lipoic acid supplements evaluated for label contents contained their stated amount of the active ingredient; only Genesis Super Alpha Lipoic Acid 100 mg failed. "None of the products contained unacceptable levels of lead and none failed to break apart properly - which is necessary for absorption," the White Plains, N.Y.-based Consumerlab.com adds. Supplements from Jarrow Formulas, Solgar, Sundown and Twinlab were among the passing products...
You may also be interested in...
The Italian firm's move to license Isturisa from Novartis last year is paying dividends already and Recordati has already tripled its peak sales forecast for the Cushing's therapy.
Pfizer is up against AstraZeneca and Sanofi in developing competing approaches to tackling the unmet need in respiratory syncytial virus (RSV). But earlier failures mean all players will need much more data to sway regulators.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.